Aspen buzzing as general syndication launched after blowout senior stage
South African pharmaceuticals company Aspen has launched its $2bn M&A facility into general syndication on a high, after lenders in the senior stage saw large scalebacks in their underwriting commitments.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: